It is possible that transcriptional inhibition of myosin Va is a fundamental early-stage molecular pathophysiology operant in all tissues in diabetes (9, 66), which likely contributes to the observed misalignment of membrane nNOS in skeletal muscles in the diabesity model. The gene discussed is MYO5A; the disease is diabetes mellitus.